About Cadence
We built Cadence because GLP-1 prescribing deserved better infrastructure.
Prescribers are doing something genuinely important — giving patients access to effective weight management medication and the support to stay on it. But the infrastructure to do that well didn't exist. Prescribers were treating without visibility. Patients were dropping out without anyone knowing. We built Cadence to fix that.
What we believe
Pharmacies are the right place to run GLP-1 services. They have the clinical relationships, the trust, and the proximity. They just needed the tools.
Patient data should work for patients and prescribers — not sit in a database doing nothing. Proper outcome tracking makes services better and justifies premium pricing.
Clinical support should be structured, not ad hoc. GLP-1 treatment follows a predictable pharmacokinetic arc. A well-designed programme should reflect that.
Interoperability matters. We use NHS coding standards (SNOMED-CT, dm+d) and are building toward NHS Login and GP Connect integration — because clinical data shouldn't be siloed.
The team
Bradley Phelps, RMN
Founder & CEO
Cadence was founded by Bradley Phelps, a Registered Mental Health Nurse (RMN) with training in cognitive behavioural therapy. Bradley was previously Product Lead at Univa Health, a digital eating disorder platform, and at Healios, one of the UK's leading NHS-contracted digital mental health providers. That experience showed him first-hand how structured digital programmes improve clinical outcomes at scale.
That combination of clinical training and product experience is why Cadence works differently. The platform is designed around how patients actually experience GLP-1 treatment — the pharmacokinetic cycle, the side effect peaks, the psychological adjustment — not how clinicians assume they do. Patient adherence is a behavioural problem, not just a clinical one.
The MHRA Technical File, clinical safety management (DCB0129/DCB0160), and hazard log are maintained in-house by someone with clinical training — not outsourced to a regulatory consultancy.
Max Roch, PhD
Chief Growth Officer
Max leads commercial growth at Cadence Health, building partnerships with pharmacy groups, GP practices, and health system stakeholders.
Before joining Cadence, Max worked in government affairs and lobbying, helping organisations navigate regulatory and policy environments to drive commercial outcomes. He has a background in SaaS business development and institutional partnerships, with experience spanning the public and private sectors.
Max holds a PhD in International Law and Economics for Sustainable Development from the Università degli Studi di Milano and an LLM (Distinction) from the Università degli Studi di Torino. He was previously a Policy, Regulation & Geopolitical Risk Advisor and held research positions at the Bank of England and the University of Edinburgh.
He brings a rare combination of commercial instinct and regulatory literacy — exactly what a health-tech company needs when selling into a regulated market.
Regulatory status
Clinical Safety
Built to MHRA Class I SaMD standards
DCB0129 / DCB0160 clinical risk management
GMDN 64275 — Patient general health self-management software
Data Protection
ICO Registration: ZC095403
UK GDPR compliant
Data hosted in London (UK residency)
Get in touch
Cadence Health Ltd · Company No. 17043196 · 3rd Floor, 86-90 Paul Street, London, EC2A 4NE